252 related articles for article (PubMed ID: 25446283)
21. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
[TBL] [Abstract][Full Text] [Related]
22. Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature.
Maekawa H; Oike Y; Kanda S; Ito Y; Yamada Y; Kurihara H; Nagai R; Suda T
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2008-14. PubMed ID: 14500293
[TBL] [Abstract][Full Text] [Related]
23. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
Kuang SQ; Bai H; Fang ZH; Lopez G; Yang H; Tong W; Wang ZZ; Garcia-Manero G
Blood; 2010 Mar; 115(12):2412-9. PubMed ID: 20061560
[TBL] [Abstract][Full Text] [Related]
24. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.
Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE
Diabetologia; 2010 Aug; 53(8):1761-71. PubMed ID: 20461358
[TBL] [Abstract][Full Text] [Related]
25. Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: gene therapy to augment nitric oxide production in bypass conduits.
Cable DG; O'Brien T; Schaff HV; Pompili VJ
Circulation; 1997 Nov; 96(9 Suppl):II-173-8. PubMed ID: 9386094
[TBL] [Abstract][Full Text] [Related]
26. Eph-B4 regulates adaptive venous remodeling to improve arteriovenous fistula patency.
Protack CD; Foster TR; Hashimoto T; Yamamoto K; Lee MY; Kraehling JR; Bai H; Hu H; Isaji T; Santana JM; Wang M; Sessa WC; Dardik A
Sci Rep; 2017 Nov; 7(1):15386. PubMed ID: 29133876
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo gene delivery of ephrin-B2 induces development of functional collateral vessels in a rabbit model of hind limb ischemia.
Katsu M; Koyama H; Maekawa H; Kurihara H; Uchida H; Hamada H
J Vasc Surg; 2009 Jan; 49(1):192-8. PubMed ID: 18950979
[TBL] [Abstract][Full Text] [Related]
28. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
29. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells.
Foubert P; Silvestre JS; Souttou B; Barateau V; Martin C; Ebrahimian TG; Leré-Déan C; Contreres JO; Sulpice E; Levy BI; Plouët J; Tobelem G; Le Ricousse-Roussanne S
J Clin Invest; 2007 Jun; 117(6):1527-37. PubMed ID: 17510705
[TBL] [Abstract][Full Text] [Related]
30. Increase of wall shear stress caused by arteriovenous fistula reduces neointimal hyperplasia after stent implantation in healthy arteries.
Liu CD; Chen F
Vascular; 2020 Aug; 28(4):396-404. PubMed ID: 32228224
[TBL] [Abstract][Full Text] [Related]
31. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
32. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
33. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
34. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
[TBL] [Abstract][Full Text] [Related]
35. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
36. Activation of EphrinB2 Signaling Promotes Adaptive Venous Remodeling in Murine Arteriovenous Fistulae.
Wang T; Liu J; Liu H; Lee SR; Gonzalez L; Gorecka J; Shu C; Dardik A
J Surg Res; 2021 Jun; 262():224-239. PubMed ID: 33039109
[TBL] [Abstract][Full Text] [Related]
37. Distinct Vascular Remodeling Pattern of Adult Rats with Carotid-Jugular Shunt.
Lü P; Jiao Q; Shimura D; Kusakari Y; Liu F; Minamisawa S
Ann Vasc Surg; 2018 May; 49():168-178. PubMed ID: 29501904
[TBL] [Abstract][Full Text] [Related]
38. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium.
Masood R; Xia G; Smith DL; Scalia P; Still JG; Tulpule A; Gill PS
Blood; 2005 Feb; 105(3):1310-8. PubMed ID: 15471957
[TBL] [Abstract][Full Text] [Related]
39. Validation of an in vitro model of human saphenous vein hyperplasia.
Castronuovo JJ; Smith TJ; Price RM
J Vasc Surg; 2002 Jan; 35(1):152-7. PubMed ID: 11802147
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory Effects of PRG4 on Migration and Proliferation of Human Venous Cells.
Wang L; Kikuchi S; Schmidt TA; Hoofnagle M; Wight TN; Azuma N; Tang GL; Sobel M; Velamoor GR; Mokadam NA; Kenagy RD
J Surg Res; 2020 Sep; 253():53-62. PubMed ID: 32320897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
